Use of NGF growth factors to treat drug-induced neuropathy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 18, 1997
Issued Date -
N/A
app pub date -
Nov 17, 1993
filing date -
Nov 13, 1990
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to the use of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor .varies. (TFG-.varies.), transforming growth factor .beta. (TGF-.beta.) and others to prevent drug-induced neuropathy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully